J9349 Medicaid reimbursement rate by state (2026)
Injection, tafasitamab-cxix, 2 mg. Medicaid pays a median of $14.40 for J9349 across 38 states, from $11.88 in New Jersey to $16.16 in Utah.
- States publishing
- 38
- National median
- $14.40units vary by state
- Lowest
- $11.88New Jersey
- Highest
- $16.16Utah
What does Medicaid pay for J9349?
38 state Medicaid programs publish a fee-for-service rate for J9349. The national median is $14.40 (units differ between states). Utah pays the most, $16.16, and New Jersey the least, $11.88, a 1.4x spread.
J9349 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 38 states with every variant, modifier and effective date.
Frequently asked questions
What does Medicaid pay for J9349?
It depends on the state. Of the 38 states with a published fee-for-service rate, the median is $14.40. Utah pays the most ($16.16) and New Jersey the least ($11.88).
Which state pays the highest Medicaid rate for J9349?
Utah, at $16.16, effective 2026-07-01.
Do managed-care plans pay the same rate for J9349?
Not necessarily. Each state's plan contracts decide whether plans must pay at least the fee-for-service rate, pay a state-set rate, or negotiate their own. The workspace shows the rule for each state, cited to the contract or statute.